Moomoo AI 已提取核心信息
Thomas F. Cowhey, SVP and Interim CFO of CVS Health Corp (CVS), completed a sale of 5,641 shares of common stock on February 28, 2024. The transaction was carried out at a price of $75.19 per share, resulting in a total value of $424,146.79. Following the sale, Cowhey's direct holdings in CVS Health Corp amount to 28,631 shares. The sale was executed as a means to cover the exercise price or tax liability by delivering or withholding securities, according to the transaction code description.
Thomas F. Cowhey, SVP and Interim CFO of CVS Health Corp (CVS), completed a sale of 5,641 shares of common stock on February 28, 2024. The transaction was carried out at a price of $75.19 per share, resulting in a total value of $424,146.79. Following the sale, Cowhey's direct holdings in CVS Health Corp amount to 28,631 shares. The sale was executed as a means to cover the exercise price or tax liability by delivering or withholding securities, according to the transaction code description.
CVS Health Corp（CVS）高级副总裁兼临时首席财务官托马斯·考威于2024年2月28日完成了5,641股普通股的出售。该交易以每股75.19美元的价格进行，总价值为424,146.79美元。出售后，Cowhey在CVS Health Corp的直接持股量为28,631股。根据交易代码的描述，此次出售是通过交付或预扣证券来支付行使价或纳税义务的一种手段。
CVS Health Corp（CVS）高级副总裁兼临时首席财务官托马斯·考威于2024年2月28日完成了5,641股普通股的出售。该交易以每股75.19美元的价格进行，总价值为424,146.79美元。出售后，Cowhey在CVS Health Corp的直接持股量为28,631股。根据交易代码的描述，此次出售是通过交付或预扣证券来支付行使价或纳税义务的一种手段。
有用
没用